Glucotrack Inc. (NASDAQ: GCTK) will implement a 1-for-15 reverse stock split effective at the opening of trading on Monday, August 31, 2026. The corporate action will consolidate 15 common shares into one, reducing the company’s outstanding share count from 11,972,157 to approximately 798,144 shares.
The split will not alter individual ownership percentages beyond rounding adjustments. Shareholders holding positions not evenly divisible by 15 will receive a fractional share to round up to the next whole share, though no fractional shares will be issued. Trading will continue on the Nasdaq Capital Market under the existing ticker GCTK, with a new CUSIP number assigned: 45824Q887.
The company secured shareholder approval for the reverse split at its annual meeting on August 18, 2026, which authorized management to execute splits at ratios up to 1-for-30. The move aims to bring Glucotrack into compliance with Nasdaq’s $1.00 minimum bid price requirement for continued listing. Following the split, the company must maintain a closing bid price of at least $1.00 for each trading day through November 9, 2026.
If Glucotrack fails to meet any Nasdaq listing requirement during this period, it will have seven calendar days to submit a compliance plan to the Nasdaq Hearings Panel. The panel will then determine whether to grant an additional exception period or proceed with delisting. VStock Transfer, LLC has been appointed as the exchange agent for the corporate action.
